National Coverage Determination (NCD) 160.18 VNS - Revised

MLN Matters Number: MM11461 Revised
Related CR Release Date: June 23, 2020
Related CR Transmittal Number: 10199NCD
Related Change Request (CR) Number: 11461
Effective Date: February 15, 2019
Implementation Date: July 22, 2020

Note: CMS revised this article to reflect the revised CR11461, issued on June 23, 2020. The CR revision clarified instructions for the MACs and changed the implementation date to July 22, 2020. In the article, CMS changed the implementation date, the CR release date, transmittal number, and the web address of the CR. All other information remains the same.

CR 11461 notifies MACs that effective for claims with dates of service on or after February 15, 2019, the Centers for Medicare & Medicaid Services (CMS) will cover Food and Drug Administration (FDA) approved vagus nerve stimulation (VNS) devices for treatment resistant depression (TRD) through Coverage with Evidence Development (CED) for patients that meet specific conditions of coverage and criteria. Please make sure your billing staffs are aware of this change.

View the complete CMS Medicare Learning Network (MLN) Matters (MM)11461.

 

            Last Updated Thu, 25 Jun 2020 15:00:54 +0000